Characteristic | % Change in LVMI | % Change in EDV | % Change in EF | |||
---|---|---|---|---|---|---|
ρ | p | ρ | p | ρ | p | |
% change in ESR | 0.006 | 0.98 | 0.561 | 0.010 | 0.201 | 0.40 |
% change in CRP | 0.191 | 0.42 | 0.034 | 0.89 | −0.043 | 0.86 |
% change in SDAI | −0.616 | 0.004 | −0.150 | 0.53 | 0.047 | 0.84 |
% change in CDAI | −0.580 | 0.007 | −0.338 | 0.15 | 0.145 | 0.54 |
Baseline age | 0.537 | 0.015 | 0.029 | 0.89 | −0.306 | 0.19 |
ACPA titer | −0.121 | 0.61 | 0.190 | 0.42 | 0.017 | 0.94 |
RF titer | 0.050 | 0.83 | 0.126 | 0.60 | −0.023 | 0.92 |
Baseline RA duration | 0.186 | 0.43 | −0.076 | 0.75 | 0.078 | 0.74 |
LVMI: left ventricular mass index; EDV: end-diastolic volume; EF: ejection fraction; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; SDAI: Simplified Disease Activity Index; CDAI: Clinical Disease Activity Index; ACPA: anticitrullinated protein antibodies; RF: rheumatoid factor; RA: rheumatoid arthritis.